Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Lupski Lab, |
RCV000577916 | SCV000583578 | likely pathogenic | Distal shortening of limbs | 2017-06-01 | criteria provided, single submitter | research | |
Mendelics | RCV000850258 | SCV001135115 | likely pathogenic | Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000850258 | SCV001520786 | likely pathogenic | Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies | 2020-06-02 | criteria provided, single submitter | clinical testing | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Revvity Omics, |
RCV000850258 | SCV003810461 | uncertain significance | Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies | 2021-04-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004722946 | SCV005331857 | pathogenic | not provided | 2024-03-25 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect by increasing binding to Rac Binding Regions and increasing transcriptional activation of downstream signaling (PMID: 35851598); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35851598, 35047859, 29276006) |
3billion | RCV000850258 | SCV005905603 | likely pathogenic | Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies | 2023-06-29 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.64; 3Cnet: 0.97). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with RAC3 related disorder (ClinVar ID: VCV000488059). The variant has been previously reported as de novo in a similarly affected individual (PMID: 29276006). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. |
OMIM | RCV000850258 | SCV000992430 | pathogenic | Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies | 2019-09-12 | no assertion criteria provided | literature only |